0000920465-20-000086.txt : 20200603 0000920465-20-000086.hdr.sgml : 20200603 20200603160507 ACCESSION NUMBER: 0000920465-20-000086 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200601 FILED AS OF DATE: 20200603 DATE AS OF CHANGE: 20200603 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hearne Michael S CENTRAL INDEX KEY: 0001759910 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36282 FILM NUMBER: 20939997 MAIL ADDRESS: STREET 1: 4147 EXECUTIVE DRIVE STREET 2: SUITE 510 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO CENTRAL INDEX KEY: 0000920465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330361285 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4550 TOWNE CENTRE COURT CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-207-4264 MAIL ADDRESS: STREET 1: 4550 TOWNE CENTRE COURT CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 wf-form4_159121468942434.xml FORM 4 X0306 4 2020-06-01 0 0000920465 LA JOLLA PHARMACEUTICAL CO LJPC 0001759910 Hearne Michael S C/O LA JOLLA PHARMACEUTICAL COMPANY 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121 0 1 0 0 Chief Financial Officer Stock Option (Right to Buy) 4.55 2020-06-01 4 A 0 100000 0 A 2030-06-01 Common Stock 100000.0 100000 D The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years. /s/ Michael Hearne 2020-06-01